Blueprint Medicines ROA - Return on Assets 2014-2025 | BPMC

Blueprint Medicines return on assets for the quarter ending March 31, 2025 was -13.05.

  • Blueprint Medicines average return on assets for 2024 was -15.71, a 65.03% decline from 2023.
  • Blueprint Medicines average return on assets for 2023 was -44.93, a 11.71% decline from 2022.
  • Blueprint Medicines average return on assets for 2022 was -50.89, a 698.9% decline from 2021.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

Blueprint Medicines ROA - Return on Assets 2014-2025 | BPMC

  • Blueprint Medicines average return on assets for 2024 was -15.71, a 65.03% decline from 2023.
  • Blueprint Medicines average return on assets for 2023 was -44.93, a 11.71% decline from 2022.
  • Blueprint Medicines average return on assets for 2022 was -50.89, a 698.9% decline from 2021.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.